Anti-Inflammatory Therapy and Immunotherapy Were Partially Effective in a Patient With Anti–N-Methyl-D-Aspartate Receptor Antibodies and a Special Subgroup of Treatment-Resistant Schizophrenia. Issue 1 (February 2016)